Skip to content

Investigating the neural mechanisms of the effect of integrative reminiscence on depressive symptoms in elderly women

brain neural mechanism of psychotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041831
Enrollment
Unknown
Registered
2021-01-07
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms

Interventions

study group:integrative reminiscence therapy
control group:12 weeks as usual

Sponsors

The Fourth People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: A. Depressive symptoms group Inclusive criteria: 1. female aged 60 years or above; 2. long-term residence in the region for more than 20 years; 3. screening by geriatric depression scale (GDS) with a score of 11-25 (mild to moderate depression); 4. communication barrier free or communication barrier free after visual and auditory correction; 5. right handedness assessed by Chinese handedness rating scale; 6. informed consent and voluntary participation in this study. B. Health control group 1. The score of GDS was less than or equal to 10; 2. The other inclusion, exclusion, exclusion and shedding criteria were the same as those of depressive symptoms group; 3. Age, gender and education level are matched with the depressive symptoms group.

Exclusion criteria

Exclusion criteria: 1.T1-weighted MRI showing lacunarinfarction > 15 mm, as determined by two radiologists with more than 5 years experience each; 2.severe somatic disease that made an individual reluctant to participate; 3.disease related to changes in brain tissue such as hypertension, diabetes mellitus, or metastatic tumors;unstable somatic diseases such as severe asthma, epilepsy,brain tumors, and other neurodegenerative diseases; or somatic diseases that might lead to mood disorders such as multiple sclerosis, thyroid disease, and chronic pain; 4.cognitive impairment as indicated in screening with the Mini-Mental State Examination (MMSE); 5.previous or current psychiatric disorder; 6.current antidepressant treatment; 7.a recent history (less than 2 months) of use of psychotropic drugs or alcoholism; 8.incompatibility with MRI due to claustrophobic tension or metal implants; and 9.participation in other research during the study period.

Design outcomes

Primary

MeasureTime frame
depressive symptoms;MRI;Reminiscence;

Secondary

MeasureTime frame
Thinking About Life Experiences;Ruminative Thought Styles;

Countries

China

Contacts

Public ContactDongmei Wu

The Fourth People's Hospital of Chengdu

741495257@qq.com+86 18190721952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026